Literature DB >> 12660802

Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci.

Z Hawi1, N Lowe, A Kirley, F Gruenhage, M Nöthen, T Greenwood, J Kelsoe, M Fitzgerald, M Gill.   

Abstract

Abnormalities in dopaminergic neurotransmission are now accepted as factors in predisposing to ADHD. Evidence of associations between dopamine transporter gene polymorphism and ADHD was first reported by Cook et al. We confirmed the DAT1 association and also identified two additional susceptibility loci at the DRD5 and DBH. Notably, none of the associated variants at these three genes are known to be expressed. Other variants within or closely mapped to the associated alleles are likely to be relevant. In this investigation, we analyse additional markers creating a high-density map across and flanking these genes, and measure intermarker linkage disequilibrium (LD). None of the newly examined markers were more strongly associated with ADHD. At DAT1, the pattern of intermarker LD and haplotype association with the phenotype between exon 9 and the 3' of the gene suggests that the functional variant at DAT1 may be located to this region. For DRD5, three markers, covering a region of approximately 68 kb including the single DRD5 exon are all associated with disease, and thus do not provide localizing information. However, the data for DBH point to a region close to the centre of the gene. Correlation between D' and physical distance was observed between markers at DAT1 and DRD5 for distances less than 50 kb. This was not the case for DBH, where LD breakdown was observed between the intron 5 and intron 9 polymorphisms although they are only 9 kb apart. Further genetic analysis is unlikely to refine the location of susceptibility variants and functional assessment of variants within associated regions is required.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12660802     DOI: 10.1038/sj.mp.4001290

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  17 in total

1.  Association study of dopamine transporter gene (DAT1) variable tandem repeat sequence (VNTR) with obsessive-compulsive disorder in Chinese Han Population.

Authors:  Shaoyan Zhang; Weihua Jiang; Xiuming Tang; Quanchen Xu; Jingli Wang; Rui Gui; Xinhua Zhang; Shiguo Liu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 2.  Role of dopamine receptors in ADHD: a systematic meta-analysis.

Authors:  Jing Wu; Haifan Xiao; Hongjuan Sun; Li Zou; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2012-05-19       Impact factor: 5.590

3.  Epistasis between neurochemical gene polymorphisms and risk for ADHD.

Authors:  Ricardo Segurado; Mark A Bellgrove; Francesca Manconi; Michael Gill; Ziarah Hawi
Journal:  Eur J Hum Genet       Date:  2011-02-02       Impact factor: 4.246

4.  Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder.

Authors:  Tiffany A Greenwood; Eun-Jeong Joo; Tatyana Shekhtman; A Dessa Sadovnick; Ronald A Remick; Paul E Keck; Susan L McElroy; John R Kelsoe
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-12-19       Impact factor: 3.568

Review 5.  Genetic aspects in attention-deficit/hyperactivity disorder.

Authors:  O Albayrak; S Friedel; B G Schimmelmann; A Hinney; J Hebebrand
Journal:  J Neural Transm (Vienna)       Date:  2008-01-16       Impact factor: 3.575

6.  Attention-Deficit Hyperactivity Disorder in the post-genomic era.

Authors:  Philip Asherson
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

7.  Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes.

Authors:  Naomi Lowe; Aiveen Kirley; Ziarih Hawi; Pak Sham; Harvey Wickham; Christopher J Kratochvil; Shelley D Smith; Saretta Y Lee; Florence Levy; Lindsey Kent; Fiona Middle; Luis A Rohde; Tatiana Roman; Eda Tahir; Yanke Yazgan; Philip Asherson; Jonathan Mill; Anita Thapar; Antony Payton; Richard D Todd; Timothy Stephens; Richard P Ebstein; Iris Manor; Cathy L Barr; Karen G Wigg; Richard J Sinke; Jan K Buitelaar; Susan L Smalley; Stan F Nelson; Joseph Biederman; Stephen V Faraone; Michael Gill
Journal:  Am J Hum Genet       Date:  2004-01-19       Impact factor: 11.025

8.  Genome-wide linkage analysis in a Dutch multigenerational family with attention deficit hyperactivity disorder.

Authors:  Rinus Vegt; Aida M Bertoli-Avella; Joke H M Tulen; Bianca de Graaf; Annemieke J M H Verkerk; Jeroen Vervoort; Carla M Twigt; Anneke Maat-Kievit; Ruud van Tuijl; Marieke van der Lijn; Michiel W Hengeveld; Ben A Oostra
Journal:  Eur J Hum Genet       Date:  2009-08-26       Impact factor: 4.246

9.  SNP discovery and haplotype analysis in the segmentally duplicated DRD5 coding region.

Authors:  Donna J E Housley; Molly Nikolas; Patrick J Venta; Kathrine A Jernigan; Irwin D Waldman; Joel T Nigg; Karen H Friderici
Journal:  Ann Hum Genet       Date:  2009-03-30       Impact factor: 1.670

10.  Study on DBH genetic polymorphisms and plasma activity in attention deficit hyperactivity disorder patients from Eastern India.

Authors:  Nipa Bhaduri; Kanyakumarika Sarkar; Swagata Sinha; Anindita Chattopadhyay; Kanchan Mukhopadhyay
Journal:  Cell Mol Neurobiol       Date:  2009-09-16       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.